LT2880180T - Būdai ir rinkiniai, skirti vėžiu sergančių pacientų atrankai - Google Patents
Būdai ir rinkiniai, skirti vėžiu sergančių pacientų atrankaiInfo
- Publication number
- LT2880180T LT2880180T LTEP13745117.5T LT13745117T LT2880180T LT 2880180 T LT2880180 T LT 2880180T LT 13745117 T LT13745117 T LT 13745117T LT 2880180 T LT2880180 T LT 2880180T
- Authority
- LT
- Lithuania
- Prior art keywords
- kits
- cancer
- methods
- screening patients
- screening
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305975 | 2012-08-06 | ||
| PCT/EP2013/066425 WO2014023706A1 (en) | 2012-08-06 | 2013-08-05 | Methods and kits for screening patients with a cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT2880180T true LT2880180T (lt) | 2019-01-25 |
Family
ID=46762994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP13745117.5T LT2880180T (lt) | 2012-08-06 | 2013-08-05 | Būdai ir rinkiniai, skirti vėžiu sergančių pacientų atrankai |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20150218650A1 (enExample) |
| EP (2) | EP2880180B1 (enExample) |
| JP (2) | JP6559566B2 (enExample) |
| AU (1) | AU2013301609B2 (enExample) |
| CA (1) | CA2881389C (enExample) |
| DK (1) | DK2880180T3 (enExample) |
| ES (1) | ES2702722T3 (enExample) |
| LT (1) | LT2880180T (enExample) |
| PL (1) | PL2880180T3 (enExample) |
| PT (1) | PT2880180T (enExample) |
| SG (1) | SG11201500922RA (enExample) |
| TR (1) | TR201819211T4 (enExample) |
| WO (1) | WO2014023706A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX356367B (es) | 2008-12-09 | 2018-05-25 | Genentech Inc | Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t. |
| SG10202005315SA (en) * | 2014-08-19 | 2020-07-29 | Nat Univ Corporation Okayama Univ | Agent for treating and/or preventing diseases associated with immune abnormalities by combining biguanide antidiabetic drug with immunosuppressive factor blocking agent or costimulatory receptor agonist |
| EP3240908A2 (en) * | 2014-12-30 | 2017-11-08 | F. Hoffmann-La Roche AG | Methods and compositions for prognosis and treatment of cancers |
| JP7281903B2 (ja) * | 2016-05-09 | 2023-05-26 | アンセルム（アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル） | 固形腫瘍を有する患者をクラス分けするための方法 |
| MX2019010295A (es) | 2017-03-01 | 2019-11-21 | Genentech Inc | Métodos de diagnóstico y terapéuticos para el cáncer. |
| KR102350221B1 (ko) | 2018-03-22 | 2022-01-14 | 스미또모 덴꼬오 하드메탈 가부시끼가이샤 | 표면 피복 절삭 공구 및 그 제조 방법 |
| EP3861137A4 (en) * | 2018-10-01 | 2022-07-13 | Nantomics, LLC | Evidence based selection of patients for clinical trials using histopathology |
| CN114072676B (zh) | 2019-06-03 | 2024-07-12 | 法国国家卫生及研究医学协会 | 调节治疗方案的方法 |
| WO2021092071A1 (en) | 2019-11-07 | 2021-05-14 | Oncxerna Therapeutics, Inc. | Classification of tumor microenvironments |
| GB202007099D0 (en) | 2020-05-14 | 2020-07-01 | Kymab Ltd | Tumour biomarkers for immunotherapy |
| EP4172621A1 (en) | 2020-06-30 | 2023-05-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies |
| JP7741831B2 (ja) | 2020-06-30 | 2025-09-18 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 術前補助療法及び根治手術後の固形がんを患っている患者の再発及び／又は死亡のリスクを予測するための方法 |
| US20250035635A1 (en) | 2022-03-17 | 2025-01-30 | Institut National De La Sante Et De La Recherche Medicale | Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4888278A (en) | 1985-10-22 | 1989-12-19 | University Of Massachusetts Medical Center | In-situ hybridization to detect nucleic acid sequences in morphologically intact cells |
| US5447841A (en) | 1986-01-16 | 1995-09-05 | The Regents Of The Univ. Of California | Methods for chromosome-specific staining |
| US6280929B1 (en) | 1986-01-16 | 2001-08-28 | The Regents Of The University Of California | Method of detecting genetic translocations identified with chromosomal abnormalities |
| US5427932A (en) | 1991-04-09 | 1995-06-27 | Reagents Of The University Of California | Repeat sequence chromosome specific nucleic acid probes and methods of preparing and using |
| US5472842A (en) | 1993-10-06 | 1995-12-05 | The Regents Of The University Of California | Detection of amplified or deleted chromosomal regions |
| US6942970B2 (en) | 2000-09-14 | 2005-09-13 | Zymed Laboratories, Inc. | Identifying subjects suitable for topoisomerase II inhibitor treatment |
| JP2002363169A (ja) * | 2001-06-08 | 2002-12-18 | Fujiyakuhin Co Ltd | 抗腫瘍活性を有する複素環化合物 |
| US7711492B2 (en) * | 2003-09-03 | 2010-05-04 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for diagnosing lymphoma types |
| US20110152115A1 (en) * | 2003-09-03 | 2011-06-23 | The United States of America, as represented by the Secretary, Department of Health and | Methods for identifying, diagnosing, and predicting survival of lymphomas |
| EP1893241A2 (en) | 2005-04-28 | 2008-03-05 | Ventana Medical Systems, Inc. | Fluorescent nanoparticles conjugated to antibodies via a peg linker |
| US20060246523A1 (en) | 2005-04-28 | 2006-11-02 | Christopher Bieniarz | Antibody conjugates |
| EP1777523A1 (en) * | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| CN104090095B (zh) | 2005-11-23 | 2016-06-01 | 文塔纳医疗系统公司 | 分子缀合物 |
| US20110070582A1 (en) * | 2008-11-03 | 2011-03-24 | Source Precision Medicine, Inc. d/b/d Source MDX | Gene Expression Profiling for Predicting the Response to Immunotherapy and/or the Survivability of Melanoma Subjects |
| ES2816625T3 (es) * | 2010-09-24 | 2021-04-05 | Niels Grabe | Medios y métodos para la predicción de la respuesta a un tratamiento de un paciente con cáncer |
| EP2663650B1 (en) * | 2011-01-11 | 2016-11-09 | INSERM - Institut National de la Santé et de la Recherche Médicale | Methods for predicting the outcome of a cancer in a patient by analysing gene expression |
-
2013
- 2013-08-05 LT LTEP13745117.5T patent/LT2880180T/lt unknown
- 2013-08-05 ES ES13745117T patent/ES2702722T3/es active Active
- 2013-08-05 TR TR2018/19211T patent/TR201819211T4/tr unknown
- 2013-08-05 JP JP2015525857A patent/JP6559566B2/ja active Active
- 2013-08-05 AU AU2013301609A patent/AU2013301609B2/en not_active Ceased
- 2013-08-05 EP EP13745117.5A patent/EP2880180B1/en active Active
- 2013-08-05 EP EP18196198.8A patent/EP3470531A1/en not_active Withdrawn
- 2013-08-05 DK DK13745117.5T patent/DK2880180T3/en active
- 2013-08-05 CA CA2881389A patent/CA2881389C/en active Active
- 2013-08-05 WO PCT/EP2013/066425 patent/WO2014023706A1/en not_active Ceased
- 2013-08-05 PT PT13745117T patent/PT2880180T/pt unknown
- 2013-08-05 US US14/420,053 patent/US20150218650A1/en not_active Abandoned
- 2013-08-05 PL PL13745117T patent/PL2880180T3/pl unknown
- 2013-08-05 SG SG11201500922RA patent/SG11201500922RA/en unknown
-
2019
- 2019-07-17 JP JP2019131862A patent/JP6995091B2/ja active Active
-
2020
- 2020-06-09 US US16/896,736 patent/US20200299784A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3470531A1 (en) | 2019-04-17 |
| CA2881389C (en) | 2022-01-04 |
| JP2019176880A (ja) | 2019-10-17 |
| TR201819211T4 (tr) | 2019-01-21 |
| WO2014023706A1 (en) | 2014-02-13 |
| US20150218650A1 (en) | 2015-08-06 |
| AU2013301609A1 (en) | 2015-02-26 |
| AU2013301609B2 (en) | 2019-03-14 |
| CA2881389A1 (en) | 2014-02-13 |
| ES2702722T3 (es) | 2019-03-05 |
| PT2880180T (pt) | 2018-12-27 |
| EP2880180A1 (en) | 2015-06-10 |
| JP6559566B2 (ja) | 2019-08-14 |
| PL2880180T3 (pl) | 2019-04-30 |
| DK2880180T3 (en) | 2019-01-14 |
| EP2880180B1 (en) | 2018-10-03 |
| JP2015530877A (ja) | 2015-10-29 |
| JP6995091B2 (ja) | 2022-01-14 |
| SG11201500922RA (en) | 2015-04-29 |
| US20200299784A1 (en) | 2020-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201500922RA (en) | Methods and kits for screening patients with a cancer | |
| IL239262A0 (en) | Scanning methods | |
| IL235826A0 (en) | Diazaspirocycloalkane and azaspirocycloalkane | |
| IL237436A0 (en) | A method for screening cancer | |
| IL235512A0 (en) | New methods | |
| EP2847593A4 (en) | METHODS FOR PREDICTING AND DETECTING THE RISK OF CANCER | |
| EP2841603A4 (en) | METHODS OF ASSESSING THE STATUS OF LUNG CANCER | |
| SG11201501838RA (en) | Completion assembly and methods for use thereof | |
| EP2808681A4 (en) | breathalyser | |
| EP2908116A4 (en) | SCREENING DEVICE AND SCREENING METHOD | |
| GB201012590D0 (en) | Methods for diagnosing cancer | |
| EP2924691A4 (en) | SCINTILLATE PANEL AND METHOD FOR PRODUCING A SCINTILLATE PANEL | |
| GB201216289D0 (en) | A screening procedure | |
| IL236436A0 (en) | Kits and methods for the detection of cyanide | |
| SI2758532T1 (sl) | Presejalni postopki in njihove uporabe | |
| PL2847339T3 (pl) | Środki i sposoby wytwarzania metanu | |
| GB201221092D0 (en) | Assemblies and methods | |
| IL234080A0 (en) | Tetrazolylhydroxyimino derivatives and methods for their production | |
| GB201213770D0 (en) | Screening methods | |
| GB201106630D0 (en) | Cancer therapy | |
| GB201202870D0 (en) | Screening methods | |
| GB201202945D0 (en) | Novel cancer therapies and methods | |
| GB201108085D0 (en) | Novel cancer therapies and methods | |
| GB201212964D0 (en) | Diagnostic and prognostic methods | |
| IL231330A0 (en) | Cancer diagnosis methods |